Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis

  • Al Khleifat, Ahmad
  • Iacoangeli, Alfredo
  • van Vugt, Joke J F A
  • Bowles, Harry
  • Moisse, Matthieu
  • Zwamborn, Ramona A J
  • van der Spek, Rick A A
  • Shatunov, Aleksey
  • Cooper-Knock, Johnathan
  • Topp, Simon
  • Byrne, Ross
  • Gellera, Cinzia
  • López-Alonso, Victoria
  • Jones, Ashley R
  • Opie-Martin, Sarah
  • Vural, Atay
  • Campos, Yolanda
  • van Rheenen, Wouter
  • Kenna, Brendan
  • Van Eijk, Kristel R
  • Kenna, Kevin
  • Weber, Markus
  • Smith, Bradley
  • Fogh, Isabella
  • Silani, Vincenzo
  • Morrison, Karen E
  • Dobson, Richard
  • van Es, Michael A
  • McLaughlin, Russell L
  • Vourc'h, Patrick
  • Chio, Adriano
  • Corcia, Philippe
  • de Carvalho, Mamede
  • Gotkine, Marc
  • Panades, Monica P
  • Mora, Jesus S
  • Shaw, Pamela J
  • Landers, John E
  • Glass, Jonathan D
  • Shaw, Christopher E
  • Basak, Nazli
  • Hardiman, Orla
  • Robberecht, Wim
  • Van Damme, Philip
  • van den Berg, Leonard H
  • Veldink, Jan H
  • Al-Chalabi, Ammar
There is a strong genetic contribution to Amyotrophic lateral sclerosis (ALS) risk, with heritability estimates of up to 60%. Both Mendelian and small effect variants have been identified, but in common with other conditions, such variants only explain a little of the heritability. Genomic structural variation might account for some of this otherwise unexplained heritability. We therefore investigated association between structural variation in a set of 25 ALS genes, and ALS risk and phenotype. As expected, the repeat expansion in the C9orf72 gene was identified as associated with ALS. Two other ALS-associated structural variants were identified: inversion in the VCP gene and insertion in the ERBB4 gene. All three variants were associated both with increased risk of ALS and specific phenotypic patterns of disease expression. More than 70% of people with respiratory onset ALS harboured ERBB4 insertion compared with 25% of the general population, suggesting respiratory onset ALS may be a distinct genetic subtype.
Repisalud
Publicación Artículo científico (JournalArticle)

Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence data

  • Al Khleifat, Ahmad
  • Iacoangeli, Alfredo
  • Jones, Ashley R
  • van Vugt, Joke J F A
  • Moisse, Matthieu
  • Shatunov, Aleksey
  • Zwamborn, Ramona A J
  • van der Spek, Rick A A
  • Cooper-Knock, Johnathan
  • Topp, Simon
  • van Rheenen, Wouter
  • Kenna, Brendan
  • Van Eijk, Kristel R
  • Kenna, Kevin
  • Byrne, Ross
  • López-Alonso, Victoria
  • Opie-Martin, Sarah
  • Vural, Atay
  • Campos, Yolanda
  • Weber, Markus
  • Smith, Bradley
  • Fogh, Isabella
  • Silani, Vincenzo
  • Morrison, Karen E
  • Dobson, Richard
  • van Es, Michael A
  • McLaughlin, Russell L
  • Vourc'h, Patrick
  • Chio, Adriano
  • Corcia, Philippe
  • de Carvalho, Mamede
  • Gotkine, Marc
  • Povedano Panades, Monica
  • Mora, Jesus S
  • Shaw, Pamela J
  • Landers, John E
  • Glass, Jonathan D
  • Shaw, Christopher E
  • Basak, Nazli
  • Hardiman, Orla
  • Robberecht, Wim
  • Van Damme, Philip
  • van den Berg, Leonard H
  • Veldink, Jan H
  • Al-Chalabi, Ammar
Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the loss of upper and lower motor neurons, leading to progressive weakness of voluntary muscles, with death following from neuromuscular respiratory failure, typically within 3 to 5 years. There is a strong genetic contribution to ALS risk. In 10% or more, a family history of ALS or frontotemporal dementia is obtained, and the Mendelian genes responsible for ALS in such families have now been identified in about 50% of cases. Only about 14% of apparently sporadic ALS is explained by known genetic variation, suggesting that other forms of genetic variation are important. Telomeres maintain DNA integrity during cellular replication, differ between sexes, and shorten naturally with age. Sex and age are risk factors for ALS and we therefore investigated telomere length in ALS. Methods: Samples were from Project MinE, an international ALS whole genome sequencing consortium that includes phenotype data. For validation we used donated brain samples from motor cortex from people with ALS and controls. Ancestry and relatedness were evaluated by principal components analysis and relationship matrices of DNA microarray data. Whole genome sequence data were from Illumina HiSeq platforms and aligned using the Isaac pipeline. TelSeq was used to quantify telomere length using whole genome sequence data. We tested the association of telomere length with ALS and ALS survival using Cox regression. Results: There were 6,580 whole genome sequences, reducing to 6,195 samples (4,315 from people with ALS and 1,880 controls) after quality control, and 159 brain samples (106 ALS, 53 controls). Accounting for age and sex, there was a 20% (95% CI 14%, 25%) increase of telomere length in people with ALS compared to controls (p = 1.1 × 10-12), validated in the brain samples (p = 0.03). Those with shorter telomeres had a 10% increase in median survival (p = 5.0×10-7). Although there was no difference in telomere length between sporadic ALS and familial ALS (p=0.64), telomere length in 334 people with ALS due to expanded C9orf72 repeats was shorter than in those without expanded C9orf72 repeats (p = 5.0×10-4). Discussion: Although telomeres shorten with age, longer telomeres are a risk factor for ALS and worsen prognosis. Longer telomeres are associated with ALS.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis

  • Al Khleifat, Ahmad
  • Iacoangeli, Alfredo
  • Vugt, Joke J. F. A. van
  • Bowles, Harry
  • Moisse, Matthieu
  • Zwamborn, Ramona A. J.
  • Spek, Rick A. A. van der
  • Shatunov, Aleksey
  • Cooper-Knock, Johnathan
  • Topp, Simon
  • Byrne, Ross
  • Gellera, Cinzia
  • López, Victoria
  • Jones, Ashley R.
  • Opie Martin, Sarah
  • Vural, Atay
  • Campos, Yolanda
  • Rheenen, Wouter van
  • Kenna, Brendan
  • Eijk, Kristel R. van
  • Kenna, Kevin
  • Weber, Markus
  • Smith, Bradley
  • Fogh, Isabella
  • Silani, Vincenzo
  • Morrison, Karen E.
  • Dobson, Richard
  • Es, Michael A. van
  • Mclaughlin, Russell L.
  • Vourc’h, Patrick
  • Chio, Adriano
  • Corcia, Philippe
  • Carvalho, Mamede de
  • Gotkine, Marc
  • Panades, Monica P.
  • Mora, Jesus S.
  • Shaw, Pamela J.
  • Landers, John E.
  • Glass, Jonathan D.
  • Shaw, Christopher E.
  • Basak, Nazli
  • Hardiman, Orla
  • Robberecht, Wim
  • Damme, Philip van
  • Berg, Leonard H. van der
  • Veldink, Jan H.
  • Al Chalabi, Ammar
There is a strong genetic contribution to Amyotrophic lateral sclerosis (ALS) risk, with heritability estimates of up to 60%. Both Mendelian and small effect variants have been identified, but in common with other conditions, such variants only explain a little of the heritability. Genomic structural variation might account for some of this otherwise unexplained heritability. We therefore investigated association between structural variation in a set of 25 ALS genes, and ALS risk and phenotype. As expected, the repeat expansion in the C9orf72 gene was identified as associated with ALS. Two other ALS-associated structural variants were identified: inversion in the VCP gene and insertion in the ERBB4 gene. All three variants were associated both with increased risk of ALS and specific phenotypic patterns of disease expression. More than 70% of people with respiratory onset ALS harboured ERBB4 insertion compared with 25% of the general population, suggesting respiratory onset ALS may be a distinct genetic subtype.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genetic variants associated with longitudinal changes in brain structure across the lifespan

  • Brouwer, Rachel M.
  • Tordesillas-Gutiérrez, Diana
  • Crespo-Facorro, Benedicto
  • Hulshoff Pol, Hilleke E.
et al., Human brain structure changes throughout the lifespan. Altered brain growth or rates of decline are implicated in a vast range of psychiatric, developmental and neurodegenerative diseases. In this study, we identified common genetic variants that affect rates of brain growth or atrophy in what is, to our knowledge, the first genome-wide association meta-analysis of changes in brain morphology across the lifespan. Longitudinal magnetic resonance imaging data from 15,640 individuals were used to compute rates of change for 15 brain structures. The most robustly identified genes GPR139, DACH1 and APOE are associated with metabolic processes. We demonstrate global genetic overlap with depression, schizophrenia, cognitive functioning, insomnia, height, body mass index and smoking. Gene set findings implicate both early brain development and neurodegenerative processes in the rates of brain changes. Identifying variants involved in structural brain changes may help to determine biological pathways underlying optimal and dysfunctional brain development and aging., The ENIGMA-Plasticity Working Group is part of the ENIGMA World Aging Center, funded by NIA grants R56 AG058854 and R01 AG058854. The ENIGMA Consortium core funding was supported by NIH Consortium Grant U54 EB020403, supported by a cross-NIH alliance that funds Big Data to Knowledge Centers of Excellence. 1000BRAINS: 1000BRAINS is a population-based cohort based on the Heinz-Nixdorf Recall Study and is supported, in part, by the German National Cohort. We thank the Heinz Nixdorf Foundation (Germany) for their generous support in terms of the Heinz Nixdorf Study. The authors are supported by the Initiative and Networking Fund of the Helmholtz Association (Svenja Caspers) and the European Union’s Horizon 2020 Research and Innovation Programme under grant agreements 785907 (Human Brain Project SGA2; Svenja Caspers, Sven Cichon and Katrin Amunts). This work was further supported by the German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders) under the auspices of the e:Med Program (grant 01ZX1314A; Sven Cichon) and by the Swiss National Science Foundation (SNSF, grant 156791; Sven Cichon). The authors acknowledge grants supporting their work from the European Union’s Horizon 2020 Research and Innovation Programme (H2020/2014–2020) under grant agreements 667302 (CoCA), 728018 (Eat2beNICE), 785907 (HBP SGA2) and 772376 (EScORIAL) and the Netherlands ALS Foundation.Additional support is received from the European Community’s Seventh Framework Programme (FP7/2007—2013) under grant agreements n° 602805 (Aggressotype), n° 603016 (MATRICS), n° 602450 (IMAGEMEND) and n° 278948 (TACTICS) and from the European Community’s Horizon 2020 Programme (H2020/2014—2020) under grant agreements n° 643051 (MiND) and n° 667302 (CoCA). FP7 Ideas: the European Research Council (ERC-230374 to D.B.). This work was supported by Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012 and PI19/024), co-financed by ERDF Funds from the European Commission, ‘A way of making Europe’, CIBERSAM; Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), European Union Structural Funds; European Union Seventh Framework Program under grant agreements FP7- HEALTH-2013-2.2.1-2-603196 (Project PSYSCAN) and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement 115916, Project PRISM and grant agreement 777394, Project AIMS-2-TRIALS), Fundación Familia Alonso, Fundación Alicia Koplowitz and Fundación Mutua Madrileña. The Horizon 2020 funded ERC Advanced Grant ‘STRATIFY’ (Brain network based stratification of reinforcement-related disorders) (695313). The FP7 project MATRICS (603016). The research leading to these results also received support from the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement 278948 (TACTICS), 602805 (Aggressotype), 603016 (MATRICS) and 602450 (Imagemend) and the Innovation Medicine Initiative grants 115300 (EU-AIMS) and 777394 (AIMS-2-TRIALS).PAFIP: PAFIP was supported by the Instituto de Salud Carlos III (PI14/00639, PI14/00918 and PI17/01056) and Fundación Instituto de Investigación Marqués de Valdecilla (NCT0235832 and NCT025KG Jebsen Stiftelsen and H2020 CoMorMent (847776).34363). European Union Marie Curie Research Training Network (MRTN-CT-2006-035987)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis

  • Al Khleifat, Ahmad
  • Iacoangeli, Alfredo
  • Vugt, Joke J. F. A. van
  • Bowles, Harry
  • Moisse, Matthieu
  • Zwamborn, Ramona A. J.
  • Spek, Rick A. A. van der
  • Shatunov, Aleksey
  • Cooper-Knock, Johnathan
  • Topp, Simon
  • Byrne, Ross
  • Gellera, Cinzia
  • López, Victoria
  • Jones, Ashley R.
  • Opie Martin, Sarah
  • Vural, Atay
  • Campos, Yolanda
  • Rheenen, Wouter van
  • Kenna, Brendan
  • Eijk, Kristel R. van
  • Kenna, Kevin
  • Weber, Markus
  • Smith, Bradley
  • Fogh, Isabella
  • Silani, Vincenzo
  • Morrison, Karen E.
  • Dobson, Richard
  • Es, Michael A. van
  • Mclaughlin, Russell L.
  • Vourc’h, Patrick
  • Chio, Adriano
  • Corcia, Philippe
  • Carvalho, Mamede de
  • Gotkine, Marc
  • Panades, Monica P.
  • Mora, Jesus S.
  • Shaw, Pamela J.
  • Landers, John E.
  • Glass, Jonathan D.
  • Shaw, Christopher E.
  • Basak, Nazli
  • Hardiman, Orla
  • Robberecht, Wim
  • Damme, Philip van
  • Berg, Leonard H. van der
  • Veldink, Jan H.
  • Al Chalabi, Ammar
There is a strong genetic contribution to Amyotrophic lateral sclerosis (ALS) risk, with heritability estimates of up to 60%. Both Mendelian and small effect variants have been identified, but in common with other conditions, such variants only explain a little of the heritability. Genomic structural variation might account for some of this otherwise unexplained heritability. We therefore investigated association between structural variation in a set of 25 ALS genes, and ALS risk and phenotype. As expected, the repeat expansion in the C9orf72 gene was identified as associated with ALS. Two other ALS-associated structural variants were identified: inversion in the VCP gene and insertion in the ERBB4 gene. All three variants were associated both with increased risk of ALS and specific phenotypic patterns of disease expression. More than 70% of people with respiratory onset ALS harboured ERBB4 insertion compared with 25% of the general population, suggesting respiratory onset ALS may be a distinct genetic subtype.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A multicentre validation study of the diagnostic value of plasma neurofilament light

  • Ashton, Nicholas J.|||0000-0002-3579-8804
  • Janelidze, Shorena
  • Al Khleifat, Ahmad|||0000-0002-7406-9831
  • Leuzy, Antoine
  • van der Ende, Emma L.|||0000-0003-2570-8796
  • Karikari, Thomas K.|||0000-0003-1422-4358
  • Benedet, AndreaL.
  • Pascoal, Tharick A.
  • Lleó, Alberto|||0000-0002-2568-5478
  • Parnetti, Lucilla|||0000-0001-5722-3967
  • Galimberti, Daniela|||0000-0002-9284-5953
  • Bonanni, Laura
  • Pilotto, Andrea|||0000-0003-2029-6606
  • Padovani, Alessandro|||0000-0002-0119-3639
  • Lycke, Jan|||0000-0002-7891-8466
  • Novakova, Lenka
  • Axelsson, Markus
  • Velayudhan, Latha|||0000-0002-7712-930X
  • Rabinovici, Gil D.
  • Miller, Bruce L.|||0000-0002-2152-4220
  • Pariante, Carmine M.|||0000-0002-9132-5091
  • Nikkheslat, Naghmeh|||0000-0002-9427-6715
  • Resnick, Susan M.
  • Thambisetty, Madhav
  • Schöll, Michael|||0000-0001-7800-1781
  • Fernández-Eulate, Gorka|||0000-0003-1112-7464
  • Gil-Bea, Francisco J.
  • Lopez de Munain, Adolfo|||0000-0002-9509-4032
  • Al-Chalabi, Ammar|||0000-0002-4924-7712
  • Rosa-Neto, Pedro|||0000-0001-9116-1376
  • Strydom, Andre
  • Svenningsson, Per
  • Stomrud, Erik
  • Santillo, Alexander
  • Aarsland, Dag|||0000-0001-6314-216X
  • van Swieten, John C.
  • Palmqvist, Sebastian|||0000-0002-9267-1930
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Blennow, Kaj|||0000-0002-1890-4193
  • Hye, Abdul|||0000-0003-2237-4823
  • Hansson, Oskar|||0000-0001-8467-7286
Increased cerebrospinal fluid neurofilament light (NfL) is a recognized biomarker for neurodegeneration that can also be assessed in blood. Here, we investigate plasma NfL as a marker of neurodegeneration in 13 neurodegenerative disorders, Down syndrome, depression and cognitively unimpaired controls from two multicenter cohorts: King's College London (n = 805) and the Swedish BioFINDER study (n = 1,464). Plasma NfL was significantly increased in all cortical neurodegenerative disorders, amyotrophic lateral sclerosis and atypical parkinsonian disorders. We demonstrate that plasma NfL is clinically useful in identifying atypical parkinsonian disorders in patients with parkinsonism, dementia in individuals with Down syndrome, dementia among psychiatric disorders, and frontotemporal dementia in patients with cognitive impairment. Data-driven cut-offs highlighted the fundamental importance of age-related clinical cut-offs for disorders with a younger age of onset. Finally, plasma NfL performs best when applied to indicate no underlying neurodegeneration, with low false positives, in all age-related cut-offs.